Caina Technology Co

Caina Technology Co CapEx/OCF

The CapEx to Operating Cash Flow Ratio of Caina Technology Co (301122.SZ) as of Nov 14, 2026 is 497.03 %. In the previous year, CapEx to Operating Cash Flow Ratio was 96.59 % — a change of 414.59% (higher).

CapEx/OCF

497.03 %

YoY

414.59%

Last updated:

CapEx to Operating Cash Flow Ratio of Caina Technology Co is 2025 497.03 % . CapEx to Operating Cash Flow Ratio of Caina Technology Co was 2024 96.59 % . It decreases by 414.59% higher compared to the previous year.

The Caina Technology Co CapEx/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/OCF
Date
CapEx/OCF
Jan 1, 2018
92.95 CNY
Jan 1, 2019
84.60 CNY
Jan 1, 2020
42.48 CNY
Jan 1, 2021
60.70 CNY
Jan 1, 2022
118.69 CNY
Jan 1, 2023
227.26 CNY
Jan 1, 2024
96.59 CNY
Jan 1, 2025
497.03 CNY
The Caina Technology Co CapEx/OCF history
YEARCapEx/OCFYoY
497.03 %+414.59%
96.59 %-57.50%
227.26 %+91.48%
118.69 %+95.53%
60.70 %+42.88%
42.48 %-49.78%
84.60 %-8.99%
92.95 %-98.88%
8,296.65 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Caina Technology Co Stock analysis

What does Caina Technology Co do? Caina Technology Co., Ltd. manufactures medical consumables including puncture needles, syringes, laboratory consumables, and masks. The company's main products are reusable copper base injection needles, aluminum base injection needles, disposable aluminum-plastic inlaid injection needles, safety blood collection needles, sheathed syringes, disposable Sterile syringes, petri dishes, and reagent tubes. Caina Technology exports its products to the United States, the United Kingdom, and the European Union, serving international markets with its medical supplies. The company generates revenue through the sale of its medical consumables to global healthcare providers and distributors. Its product range targets hospitals, clinics, and laboratories requiring reliable medical equipment. Caina Technology's focus on exporting to developed markets ensures steady demand for its high-quality, compliant medical products. Caina Technology's business model relies on manufacturing and exporting medical consumables to international customers. The firm's product portfolio includes specialized items like safety blood collection needles and sterile syringes, which are essential for healthcare facilities. By targeting key regions such as the United States, United Kingdom, and European Union, the company secures consistent sales channels for its medical supplies. Caina Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Caina Technology Co stock

CapEx to Operating Cash Flow Ratio of Caina Technology Co is 497.03 % in 2025.

CapEx to Operating Cash Flow Ratio of Caina Technology Co changed from 96.59 % to 497.03 %, representing a 414.59% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Operating Cash Flow Ratio Caina Technology Co since 2006 – with annual values, charts, and detailed analysis.

The CapEx/OCF ratio shows what percentage of operating cash flow is reinvested in capital assets. Lower ratios indicate more free cash available for shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Operating Cash Flow Ratio's Caina Technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Operating Cash Flow Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Operating Cash Flow Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Caina Technology Co

All Key Metrics — Caina Technology Co